
A highly skilled professional with expertise in independent non-medical prescribing and clinical medication review, dedicated to optimising patient care through evidence-based clinical decision making. Proficient in long-term condition management and medicines optimisation, ensuring comprehensive patient assessment and consultation. Committed to safeguarding and risk assessment while fostering multidisciplinary team collaboration to enhance healthcare outcomes.
•Built on IP qualification through focused CPD and clinical exposure, enabling independent prescribing of GLP-1 therapies.
•Independently assess, diagnose, and initiate treatment plans for patients with type 2 diabetes and/or obesity. •
Safely prescribe GLP-1 receptor agonists (e.g., Semaglutide, Liraglutide), ensuring alignments with NICE guidelines and local protocols.
•Monitor efficacy, tolerability, ad safety of GLP-1 therapies through regular patient reviews and clinical parameters (e.g. HbA1c, weight, renal function).
•Provide structured counselling and support on lifestyle modification and injection technique.